1188TiP NICE-NEC, a phase II study of platinum-doublet chemotherapy in combination with nivolumab as first-line treatment in subjects with unresectable, locally advanced or metastatic grade 3 neuroendocrine neoplasms (NENs) of the gastroenteropancreatic tract or of unknown origin. GETNE-T1913
- Resource Type
- Source
- Annals of Oncology. 31:S783
- Subject
Oncology medicine.medical_specialty Chemotherapy business.industry medicine.medical_treatment Locally advanced Phases of clinical research Nice Hematology First line treatment Internal medicine medicine Nivolumab business computer computer.programming_language - Language
- ISSN
- 0923-7534